Market News
Clovis Oncology (NASDAQ: CLVS): Q4 2019 Earnings Snapshot
— Clovis Oncology (NASDAQ: CLVS) reported a fourth-quarter 2019 loss of $1.81 per share versus a loss of $1.71 per share expected. — Product revenues…